{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:14:34Z","timestamp":1791432874078,"version":"4.3.3"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1136\/ard.2006.066787","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T01:59:48Z","timestamp":1177466388000},"page":"1255-1258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Optic neuritis occurring with anti-tumour necrosis factor \u03b1 therapy"],"prefix":"10.1016","volume":"66","author":[{"given":"Ismail","family":"Simsek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Pay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gungor","family":"Sobaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Dinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.066787_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00002018-200427050-00003","article-title":"Safety of tumour necrosis factor-alpha antagonists","volume":"27","author":"Khanna","year":"2004","journal-title":"Drug Saf"},{"key":"10.1136\/ard.2006.066787_bib2","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.066787_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00054725-200401000-00004","article-title":"Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease","volume":"10","author":"Thomas","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1136\/ard.2006.066787_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain\u2013Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.066787_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.optm.2005.07.003","article-title":"Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management","volume":"76","author":"Bhatti","year":"2005","journal-title":"Optometry"},{"key":"10.1136\/ard.2006.066787_bib6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1345\/aph.1G279","article-title":"Optic neuritis with concurrent etanercept and isoniazid therapy","volume":"39","author":"Noguera-Pons","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1136\/ard.2006.066787_bib7","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.7326\/0003-4819-140-8-200404200-00037-w4","article-title":"Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease","volume":"140","author":"Strong","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.066787_bib8","first-page":"985","article-title":"Retrobulbar optic neuritis associated with infliximab","volume":"120","author":"Foroozan","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1136\/ard.2006.066787_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.326.7389.579","article-title":"Bilateral anterior toxic optic neuropathy and the use of infliximab","volume":"326","author":"ten Tusscher","year":"2003","journal-title":"BMJ"},{"key":"10.1136\/ard.2006.066787_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archopht.122.5.793","article-title":"Infliximab-associated retrobulbar optic neuritis","volume":"122","author":"Mejico","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1136\/ard.2006.066787_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0181-5512(05)81044-7","article-title":"[Optic neuritis associated with infliximab]","volume":"28","author":"Tran","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"10.1136\/ard.2006.066787_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaapos.2005.12.002","article-title":"Optic neuritis associated with etanercept therapy for juvenile arthritis","volume":"10","author":"Tauber","year":"2006","journal-title":"J AAPOS"},{"key":"10.1136\/ard.2006.066787_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2006.01.012","article-title":"Adalimumab-associated optic neuritis","volume":"244","author":"Chung","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1136\/ard.2006.066787_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","article-title":"Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?","volume":"44","author":"Robinson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.066787_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1378\/chest.62.1.71","article-title":"Isoniazid: a review with emphasis on adverse effects","volume":"62","author":"Goldman","year":"1972","journal-title":"Chest"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724346990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.066787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T04:10:14Z","timestamp":1737259814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724346990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0003496724346990"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.066787","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optic neuritis occurring with anti-tumour necrosis factor \u03b1 therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.066787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}